• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常驻非心肌细胞的直接重编程及其在体内心脏再生中的潜力。

Direct Reprogramming of Resident Non-Myocyte Cells and Its Potential for In Vivo Cardiac Regeneration.

机构信息

Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.

出版信息

Cells. 2023 Apr 15;12(8):1166. doi: 10.3390/cells12081166.

DOI:10.3390/cells12081166
PMID:37190075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10136631/
Abstract

Cardiac diseases are the foremost cause of morbidity and mortality worldwide. The heart has limited regenerative potential; therefore, lost cardiac tissue cannot be replenished after cardiac injury. Conventional therapies are unable to restore functional cardiac tissue. In recent decades, much attention has been paid to regenerative medicine to overcome this issue. Direct reprogramming is a promising therapeutic approach in regenerative cardiac medicine that has the potential to provide in situ cardiac regeneration. It consists of direct cell fate conversion of one cell type into another, avoiding transition through an intermediary pluripotent state. In injured cardiac tissue, this strategy directs transdifferentiation of resident non-myocyte cells (NMCs) into mature functional cardiac cells that help to restore the native tissue. Over the years, developments in reprogramming methods have suggested that regulation of several intrinsic factors in NMCs can help to achieve in situ direct cardiac reprogramming. Among NMCs, endogenous cardiac fibroblasts have been studied for their potential to be directly reprogrammed into both induced cardiomyocytes and induced cardiac progenitor cells, while pericytes can transdifferentiate towards endothelial cells and smooth muscle cells. This strategy has been indicated to improve heart function and reduce fibrosis after cardiac injury in preclinical models. This review summarizes the recent updates and progress in direct cardiac reprogramming of resident NMCs for in situ cardiac regeneration.

摘要

心脏病是全球发病率和死亡率的首要原因。心脏的再生潜力有限;因此,心脏损伤后不能补充丢失的心肌组织。传统疗法无法恢复功能性心肌组织。近几十年来,人们越来越关注再生医学来解决这个问题。直接重编程是再生心脏医学中一种很有前途的治疗方法,它有可能提供原位心脏再生。它包括将一种细胞类型直接转化为另一种细胞类型,避免通过中间多能状态进行转化。在受损的心肌组织中,这种策略指导驻留非心肌细胞(NMC)向成熟的功能性心肌细胞的转分化,有助于恢复原生组织。多年来,重编程方法的发展表明,调节 NMC 中的几种内在因素有助于实现原位直接心脏重编程。在 NMC 中,内源性心肌成纤维细胞已被研究用于直接重编程为诱导性心肌细胞和诱导性心肌祖细胞,而周细胞可向内皮细胞和平滑肌细胞转分化。在临床前模型中,该策略已被证明可改善心脏功能并减少心脏损伤后的纤维化。本文综述了近年来驻留 NMC 的直接心脏重编程用于原位心脏再生的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a04/10136631/405643b87215/cells-12-01166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a04/10136631/74a26bf760d0/cells-12-01166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a04/10136631/c98fe6dc3ab6/cells-12-01166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a04/10136631/405643b87215/cells-12-01166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a04/10136631/74a26bf760d0/cells-12-01166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a04/10136631/c98fe6dc3ab6/cells-12-01166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a04/10136631/405643b87215/cells-12-01166-g003.jpg

相似文献

1
Direct Reprogramming of Resident Non-Myocyte Cells and Its Potential for In Vivo Cardiac Regeneration.常驻非心肌细胞的直接重编程及其在体内心脏再生中的潜力。
Cells. 2023 Apr 15;12(8):1166. doi: 10.3390/cells12081166.
2
In situ reprogramming of cardiac fibroblasts into cardiomyocytes in mouse heart with chemicals.利用化学物质在小鼠心脏中将心脏成纤维细胞原位重编程为心肌细胞。
Acta Pharmacol Sin. 2024 Nov;45(11):2290-2299. doi: 10.1038/s41401-024-01308-6. Epub 2024 Jun 18.
3
Novel Directly Reprogrammed Smooth Muscle Cells Promote Vascular Regeneration as Microvascular Mural Cells.新型直接重编程平滑肌细胞作为微血管壁细胞促进血管再生。
Circulation. 2025 Apr 15;151(15):1076-1094. doi: 10.1161/CIRCULATIONAHA.124.070217. Epub 2025 Feb 13.
4
Short-Term Memory Impairment短期记忆障碍
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Partial Cell Fate Transitions to Promote Cardiac Regeneration.部分细胞命运转变以促进心脏再生。
Cells. 2024 Dec 4;13(23):2002. doi: 10.3390/cells13232002.
7
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
8
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
9
Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.诱导多能干细胞技术作为一种潜在的脊髓损伤临床治疗方法的系统评价。
Cell Transplant. 2013;22(4):571-617. doi: 10.3727/096368912X655208. Epub 2012 Aug 27.
10
Stepwise Administration of Bone-Targeted Lipid Nanoparticles Encapsulating Valproic Acid and TUDCA Facilitates In Vivo Direct Reprogramming for Osteoporosis Treatment.逐步给予包裹丙戊酸和牛磺熊去氧胆酸的骨靶向脂质纳米颗粒有助于体内直接重编程以治疗骨质疏松症。
Tissue Eng Regen Med. 2025 Jun 24. doi: 10.1007/s13770-025-00738-5.

引用本文的文献

1
Cellular Models of Aging and Senescence.衰老与细胞衰老的细胞模型
Cells. 2025 Aug 18;14(16):1278. doi: 10.3390/cells14161278.
2
Injectable Stem Cell-Based Therapies for Myocardial Regeneration: A Review of the Literature.用于心肌再生的基于干细胞的注射疗法:文献综述
J Funct Biomater. 2025 Apr 23;16(5):152. doi: 10.3390/jfb16050152.
3
A biodegradable, microstructured, electroconductive and nano-integrated drug eluting patch (MENDEP) for myocardial tissue engineering.一种用于心肌组织工程的可生物降解、微结构化、导电且纳米集成的药物洗脱贴片(MENDEP)。

本文引用的文献

1
Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction.直接重编程改善慢性心肌梗死的心脏功能并逆转纤维化。
Circulation. 2023 Jan 17;147(3):223-238. doi: 10.1161/CIRCULATIONAHA.121.058655. Epub 2022 Dec 12.
2
Direct Cardiac Epigenetic Reprogramming through Codelivery of 5'Azacytidine and miR-133a Nanoformulation.通过 5'氮杂胞苷和 miR-133a 纳米制剂的共递送实现心脏的直接表观遗传重编程。
Int J Mol Sci. 2022 Dec 2;23(23):15179. doi: 10.3390/ijms232315179.
3
Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair.
Bioact Mater. 2025 Apr 14;50:246-272. doi: 10.1016/j.bioactmat.2025.04.008. eCollection 2025 Aug.
4
STAT3 Signaling Pathway in Health and Disease.健康与疾病中的信号转导和转录激活因子3(STAT3)信号通路
MedComm (2020). 2025 Mar 30;6(4):e70152. doi: 10.1002/mco2.70152. eCollection 2025 Apr.
5
Partial Cell Fate Transitions to Promote Cardiac Regeneration.部分细胞命运转变以促进心脏再生。
Cells. 2024 Dec 4;13(23):2002. doi: 10.3390/cells13232002.
6
Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction.心肌梗死后内源性哺乳动物心脏再生的最新见解。
Int J Mol Sci. 2024 Nov 1;25(21):11747. doi: 10.3390/ijms252111747.
7
Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential.Sall4 和 Gata4 诱导心肌成纤维细胞向具有心脏发生潜力的部分多能状态转变。
Sci Rep. 2024 Oct 15;14(1):24182. doi: 10.1038/s41598-024-73975-8.
基于细胞重编程的心脏再生修复方法的研究进展。
Cells. 2022 Dec 3;11(23):3914. doi: 10.3390/cells11233914.
4
Apelin-13 Increases Functional Connexin-43 through Autophagy Inhibition via AKT/mTOR Pathway in the Non-Myocytic Cell Population of the Heart.Apelin-13 通过 AKT/mTOR 通路抑制自噬增加心脏非心肌细胞群体中功能性连接蛋白 43 的表达。
Int J Mol Sci. 2022 Oct 28;23(21):13073. doi: 10.3390/ijms232113073.
5
TBX20 Improves Contractility and Mitochondrial Function During Direct Human Cardiac Reprogramming.TBX20 改善直接人心肌重编程过程中的收缩性和线粒体功能。
Circulation. 2022 Nov 15;146(20):1518-1536. doi: 10.1161/CIRCULATIONAHA.122.059713. Epub 2022 Sep 14.
6
Lipoplexes for effective in vitro delivery of microRNAs to adult human cardiac fibroblasts for perspective direct cardiac cell reprogramming.用于将 microRNAs 有效递送至成人人心肌成纤维细胞的脂质体,用于前瞻性的直接心脏细胞重编程。
Nanomedicine. 2022 Sep;45:102589. doi: 10.1016/j.nano.2022.102589. Epub 2022 Jul 28.
7
Matrix Metalloproteinase 2 as a Pharmacological Target in Heart Failure.基质金属蛋白酶2作为心力衰竭的一个药理学靶点。
Pharmaceuticals (Basel). 2022 Jul 25;15(8):920. doi: 10.3390/ph15080920.
8
Conservation of miR combo based direct cardiac reprogramming.基于miR组合的直接心脏重编程的保守性。
Biochem Biophys Rep. 2022 Jul 13;31:101310. doi: 10.1016/j.bbrep.2022.101310. eCollection 2022 Sep.
9
p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation.p63 沉默诱导表观遗传修饰以增强人心肌成纤维细胞向心肌细胞样分化。
Sci Rep. 2022 Jul 6;12(1):11416. doi: 10.1038/s41598-022-15559-y.
10
Fibroblast fate determination during cardiac reprogramming by remodeling of actin filaments.在心脏重编程过程中通过肌动蛋白丝重塑决定成纤维细胞命运。
Stem Cell Reports. 2022 Jul 12;17(7):1604-1619. doi: 10.1016/j.stemcr.2022.05.004. Epub 2022 Jun 9.